N-butyl-N-(3-chloro-4-fluorophenyl)quinolin-5-amine

ID: ALA4872346

PubChem CID: 164619464

Max Phase: Preclinical

Molecular Formula: C19H18ClFN2

Molecular Weight: 328.82

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCCN(c1ccc(F)c(Cl)c1)c1cccc2ncccc12

Standard InChI:  InChI=1S/C19H18ClFN2/c1-2-3-12-23(14-9-10-17(21)16(20)13-14)19-8-4-7-18-15(19)6-5-11-22-18/h4-11,13H,2-3,12H2,1H3

Standard InChI Key:  PBVOXIKRAZJPAE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   13.7753  -17.6975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7741  -18.5171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4822  -18.9260    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.4804  -17.2887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1890  -17.6939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1898  -18.5129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8983  -18.9200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6066  -18.5092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6018  -17.6870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8927  -17.2837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8884  -16.4665    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5939  -16.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2992  -16.4624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0043  -16.0507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0004  -15.2327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2855  -14.8280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5834  -15.2420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1785  -16.0617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4730  -16.4740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7631  -16.0692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0576  -16.4815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7053  -14.8194    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   18.7139  -16.4559    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 11 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 15 22  1  0
 14 23  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4872346

    ---

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16-F10 (4610 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 328.82Molecular Weight (Monoisotopic): 328.1143AlogP: 5.97#Rotatable Bonds: 5
Polar Surface Area: 16.13Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 5.92CX LogP: 5.87CX LogD: 5.85
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.57Np Likeness Score: -1.62

References

1. Ren Y, Ruan Y, Cheng B, Li L, Liu J, Fang Y, Chen J..  (2021)  Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activities.,  46  [PMID:34455231] [10.1016/j.bmc.2021.116376]

Source